Evidence map›Paper›PMID 41484705›Full record

ArticleBMC medical imaging2026

Prediction of lymph node metastasis in non-small cell lung cancer and its correlation with Ki-67 expression: a comparative study between intravoxel incoherent motion imaging and

Wei Wei, Qianqian Chen, Nan Meng, Xinyu Wang, Yue Liu, Jingwen Zhang, Yaping Wu, Jiayin Pan, Zhun Huang, Yang Yang and 4 more

Abstract readComparative Study
In one paragraph

Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Wei Wei *Department of Radiology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China.
Qianqian Chen *Department of Radiology, Department of Radiology, Zhengzhou University People's Hospital, & Henan Provincial People's Hospital Zhengzhou, Zhengzhou, China.
Nan MengDepartment of Radiology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China.
Xinyu WangDepartment of Radiology, Henan University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, China.
Yue LiuDepartment of Radiology, Department of Radiology, Zhengzhou University People's Hospital, & Henan Provincial People's Hospital Zhengzhou, Zhengzhou, China.
Jingwen ZhangDepartment of Radiology, Department of Radiology, Zhengzhou University People's Hospital, & Henan Provincial People's Hospital Zhengzhou, Zhengzhou, China.
Yaping WuDepartment of Radiology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China.
Jiayin PanDepartment of Radiology, Department of Radiology, Zhengzhou University People's Hospital, & Henan Provincial People's Hospital Zhengzhou, Zhengzhou, China.
Zhun HuangDepartment of Radiology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China.
Yang YangBeijing United Imaging Healthcare Co., Ltd, Beijing, China.
Zhe WangCentral Research Institute, United Imaging Healthcare Group, Shanghai, China.
Qiuyu LiuDepartment of Pathology, Provincial Medical Clinical School of Zhengzhou University & Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Fangfang FuDepartment of Radiology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China. fufangf@126.com.
Meiyun WangDepartment of Radiology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China. mywang@zzu.edu.cn.

Funding

Henan medical science and technology project LHGJ20210001National Key Research and Development Program of China 2023YFC2414200the Key Project of Henan Province Medical Science and Technology Project's LHGJ20240036the National Natural Science Foundation of China 82441022the Natural Science Foundation of Henan Province 252300420565the Science and Technology Project of Henan Province 252102311105the Special Training Program for Clinical Research Physicians under the "Three 100" lnitiative of Henan Province HNCRD202406
6 · The paper itself

Abstract

backgroundIntegrated positron emission tomography/magnetic resonance (PET/MRI) may have the potential to evaluate lymph node metastasis (LNM) status and Ki-67 proliferation index in patients with non-small cell lung cancer.

methodsThis study enrolled 92 pathologically confirmed NSCLC patients. Quantitative analysis of metabolic parameters, such as maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), total lesion glycolysis (TLG), and IVIM parameters including apparent diffusion coefficient (ADC), true diffusion coefficient (D), pseudo diffusion coefficient (D*), perfusion fraction (f), and distributed diffusion coefficient (DDC). The predictive performance of each parameter for LNM was assessed using receiver operating characteristic (ROC) curve analysis, and a multivariate logistic regression model was constructed to establish the optimal combined predictive model. Spearman correlation analysis was used to explore the relationship between imaging parameters and Ki-67 expression.

resultsLNM prediction: The LNM-positive group exhibited lower ADC, D, and DDC (all P < 0.05) compared to the LNM-negative group. Multivariate analysis identified MTV and DDC as independent predictors of LNM. The combined model (MTV + DDC) achieved an AUC of 0.821 (sensitivity 79.49%, specificity 73.59%), significantly outperforming individual parameters (P < 0.05). Ki-67 correlation: SUVmax, MTV, and TLG showed positive correlations with Ki-67 (r = 0.232 to -0.300, P < 0.05), while ADC and D values exhibited negative correlations (r = − 0.327 to − 0.240, P < 0.05). No significant association was observed between D*, f, and Ki-67 (P > 0.05).

conclusionIntegrated PET/MRI, by combining metabolic (MTV) and diffusion (DDC) parameters, significantly improves the predictive accuracy for LNM in NSCLC. Additionally, metabolic and select IVIM parameters correlate with Ki-67 expression.

Indexed as

Carcinoma, Non-Small-Cell LungKi-67 AntigenLung NeoplasmsLymphatic MetastasisPositron-Emission TomographyAdultAgedFemaleFluorodeoxyglucose F18HumansMagnetic Resonance ImagingMaleMiddle AgedMultimodal ImagingRadiopharmaceuticalsFluorodeoxyglucose F18Ki-67 AntigenRadiopharmaceuticalsIntravoxel incoherent motion imagingKi-67Lymph node metastasisNon-small cell lung cancerPET/MRI

Identifiers

PMID41484705
PMCPMC12866322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.